Nanopatterned medical device with enhanced cellular interaction
A medical device for delivering a drug compound through a stratum corneum includes a support having an aperture, an array of microneedles extending outwardly from the support, a plurality of nanostructures associated with each microneedle, and a reservoir wherein the drug compound is retained. At least one microneedle contains a shaft extending from the support. The shaft includes a tip configured to penetrate the stratum corneum. The shaft defines a channel extending from the support to the tip. The channel is in at least partial alignment with the aperture. At least some of the microneedles of the array of microneedles each have a cross-sectional dimension of from about 1 micrometer to about 1 millimeter. At least some of the nanostructures have a cross-sectional dimension less than about 500 nanometers and greater than about 5 nanometers and an aspect ratio of from about 0.2 to about 5.
1. A medical device for delivering a drug compound through a stratum corneum and to a subdermal location, the medical device comprising:
a support having an aperture;
an array of microneedles that extend outwardly from the support, wherein at least one microneedle contains a shaft extending from the support, the shaft including a tip configured to penetrate the stratum corneum, the shaft defining a channel extending from the support to the tip, the channel being in at least partial alignment with the aperture of the support, wherein at least some of the microneedles of the array of microneedles each have a cross-sectional dimension of from about 1 micrometer to about 1 millimeter;
a plurality of nanostructures associated with each microneedle of the array of microneedles, wherein the plurality of nanostructures are arranged in a pattern that comprises a fractal and/or fractal-like geometry having a fractal dimension between about 1.2 and about 5; and
a reservoir wherein the drug compound is retained, the reservoir being in fluid communication with the aperture of the support and the channel of the microneedle for delivery of the drug compound to the subdermal location.
2. The medical device of claim 1 , wherein the at least some of the nanostructures have a cross-sectional dimension less than about 500 nanometers, and greater than about 5 nanometers.
3. The medical device of claim 1 , wherein each of the plurality of nanostructures has approximately the same cross-sectional dimension as one another.
4. The medical device of claim 1 further comprising a plurality of microstructures associated with each microneedle of the array of microneedles, wherein each of the plurality of nanostructures has a cross-sectional dimension smaller than each of the plurality of microstructures.
5. The medical device of claim 4 , wherein each of the plurality of microstructures has a cross-sectional dimension greater than about 500 nanometers and less than about 10 micrometers, and wherein each of the plurality of nanostructures has a cross-sectional dimension less than about 300 nanometers.
6. The medical device of claim 4 , further comprising a plurality of second nanostructures, each second nanostructure of the plurality of second nanostructures having a cross-sectional dimension less than the cross-sectional dimension of each of the plurality of microstructures and greater than the cross-sectional dimension of each nanostructure of the plurality of nanostructures.
7. The medical device of claim 4 , wherein the at least some of the nanostructures have a cross-sectional dimension from about 20 nanometers to about 400 nanometers, and wherein at least some of the microstructures have a cross-sectional dimension from about 600 nanometers to about 1.5 micrometers.
8. The medical device of claim 1 , wherein the at least some of the nanostructures have a center-to-center spacing from about 50 nanometers to about 1 micrometer.
9. The medical device of claim 1 , wherein a ratio of an average of a cross-sectional dimension of two adjacent nanostructures to a center-to-center spacing between the two adjacent nanostructures is between about 1:1 and about 1:4.
10. The medical device of claim 1 , wherein each nanostructure of the plurality of nanostructures has a height from about 10 nanometers to about 1 micrometer.
11. The medical device of claim 1 , wherein the at least some of the nanostructures have an aspect ratio from about 0.2 to about 5.
12. The medical device of claim 1 further comprising a nanopatterned film disposed on each microneedle of the array of microneedles, the nanopatterned film including the plurality of nanostructures.
13. A medical device for delivering a drug compound through a stratum corneum and to a subdermal location, the medical device comprising:
a support having an aperture;
an array of microneedles that extend outwardly from the support, wherein at least one microneedle contains a shaft extending from the support, the shaft including a tip configured to penetrate the stratum corneum, the shaft defining a channel extending from the support to the tip, the channel being in at least partial alignment with the aperture of the support, wherein at least some of the microneedles of the array of microneedles each have a cross-sectional dimension of from about 1 micrometer to about 1 millimeter;
a plurality of nanostructures associated with each microneedle of the array of microneedles, the plurality of nanostructures arranged in a fractal and/or fractal-like pattern having a fractal dimension between about 1.2 and about 5; and
a reservoir wherein the drug compound is retained, the reservoir being in fluid communication with the aperture of the support and the channel of the microneedle for delivery of the drug compound to the subdermal location.
14. The medical device of claim 13 , wherein the pattern has a fractal dimension from about 1.5 to about 2.5.
15. The medical device of claim 13 , wherein the pattern has a fractal dimension of about 2.5.
16. The medical device of claim 13 , further comprising a nanopatterned film disposed on each microneedle of the array of microneedles, the nanopatterned film including the plurality of nanostructures.
17. A medical device for delivering a drug compound through a stratum corneum and to a subdermal location, the medical device comprising:
a microneedle having an exterior surface, wherein the microneedle contains a shaft defining a channel extending therethrough;
a nanopatterned film disposed on the exterior surface of the microneedle, the nanopatterned film comprising a plurality of nanostructures, wherein the plurality of nanostructures are arranged in a pattern that comprises a fractal and/or fractal-like geometry having a fractal dimension between about 1.2 and about 5; and
a reservoir wherein the drug compound is retained, the reservoir being in fluid communication with the channel of the microneedle for delivery of the drug compound to the subdermal location.
18. The medical device of claim 17 , wherein the plurality of nanostructures are arranged in a pattern having a fractal dimension between about 1.5 and 2.5.
19. The medical device of claim 17 , wherein the nanopatterned film further comprises a plurality of microstructures, wherein each of the plurality of nanostructures has a cross-sectional dimension smaller than each of the plurality of microstructures.
20. The medical device of claim 19 , wherein the plurality of nanostructures defines a plurality of first nanostructures, wherein the nanopatterned film further comprises a plurality of second nanostructures, wherein each second nanostructure of the plurality of second nanostructures has a cross-sectional dimension less than the cross-sectional dimension of each microstructure of the plurality of microstructures and greater than the cross-sectional dimension of each nanostructure of the plurality of first nanostructures.